Colgate-Palmolive Company $CL Shares Sold by TD Asset Management Inc

TD Asset Management Inc lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 17.7% in the 3rd quarter, Holdings Channel reports. The fund owned 2,911,008 shares of the company’s stock after selling 627,396 shares during the quarter. TD Asset Management Inc’s holdings in Colgate-Palmolive were worth $232,706,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Brighton Jones LLC increased its position in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the last quarter. Woodline Partners LP increased its holdings in shares of Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. lifted its holdings in Colgate-Palmolive by 2.0% in the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after acquiring an additional 245 shares during the last quarter. Resonant Capital Advisors LLC purchased a new stake in Colgate-Palmolive in the second quarter valued at $233,000. Finally, Envestnet Asset Management Inc. lifted its stake in shares of Colgate-Palmolive by 0.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock valued at $61,662,000 after purchasing an additional 2,768 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Market/momentum upgrade: CL has been upgraded on relative strength metrics and is noted as up ~23% YTD, which has sparked momentum buying and technical interest. This upgrade supports further inflows from momentum-focused funds and retail investors. Colgate-Palmolive Stock Up 23% So Far This Year, Shines Brightly. Gets Rating Upgrade.
• Positive Sentiment: Analyst/portfolio spotlight: Zacks and other outlets are highlighting CL in model portfolios and focus lists after recent strength—this can attract coverage-driven buying and validate recent upgrades. Take the Zacks Approach to Beat the Markets
• Positive Sentiment: Emerging-market sales/brand initiative: Colgate-Palmolive (India) announced a Haryana government tie-up to deliver oral-health education to millions of students—strengthening local brand presence and long-term category penetration. Colgate-Palmolive, Haryana Government Tie Up
• Positive Sentiment: Industry tailwinds: A broad cosmetics/personal-care market report lists Colgate among major players and forecasts sector growth—supportive for medium-term revenue/innovation upside. Global Cosmetics Market Competitive Landscape Report 2025
• Neutral Sentiment: Analyst commentary and peer comparisons: Multiple pieces compare CL with peers (e.g., P&G) across margins, pricing power and valuation—useful context but not a direct catalyst. Procter & Gamble vs Colgate
• Neutral Sentiment: Technical watch: Coverage notes rising relative strength but CL remains shy of key thresholds—momentum may continue but technical resistance could slow gains. Colgate-Palmolive shows rising relative strength; still shy of key threshold
• Negative Sentiment: Execution risk disclosure: Analysts flagged execution risks tied to Colgate’s new three‑year strategic growth and productivity program—if execution slips, margins and guidance could be at risk. Execution Risks Loom Over Colgate-Palmolive’s 3-Year Program
• Negative Sentiment: Governance/proxy friction: Colgate plans to oppose a shareholder proposal to remove DEI-related board selection criteria—this governance fight could create investor uncertainty and negative headlines. Colgate-Palmolive plans to defend DEI criteria for board selection
• Negative Sentiment: Options/short-term hedging: Unusual options flow shows a big jump in put buying (18,150 puts), indicating some investors are hedging or betting on near-term weakness—could amplify volatility.

Insider Buying and Selling

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the sale, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. This represents a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 184,683 shares of company stock worth $17,486,693 in the last quarter. Corporate insiders own 0.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $98.08 on Wednesday. The stock has a 50 day moving average of $86.35 and a two-hundred day moving average of $82.43. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. The company has a market capitalization of $79.06 billion, a P/E ratio of 37.43, a P/E/G ratio of 4.38 and a beta of 0.29. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period last year, the firm earned $0.91 EPS. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Piper Sandler boosted their target price on Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Colgate-Palmolive in a research note on Friday. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Finally, Jefferies Financial Group boosted their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.